Regeneron to acquire decibel therapeutics, strengthening gene therapy and hearing loss programs

Proposed acquisition builds on existing collaboration between decibel and regeneron, will accelerate and further resource key gene therapy programs for hearing loss
REGN Ratings Summary
Quant
REGN Quant Ranking
Sector
Industry
Quant Rating
Quant Score